Effectiveness of adding nitazoxanide to the standard triple therapy in the eradication of Helicobacter pylori infectio
Phase 4
- Conditions
- Digestive System
- Registration Number
- PACTR202112686695509
- Lead Sponsor
- o
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Any Naive Patient above the age of 18 years old with H.pylori infection will be included in the study. Patients infected by H.pylori will be diagnosed by stool antigen test.
Exclusion Criteria
Patients aged less than 18 years, prior gastric surgery, Prior H. pylori eradication therapy, recent intake of antibiotics, proton pump inhibitor (PPI), histamine (H2) receptor blockers, nonsteroidal or anti-inflammatory drugs within the last month, known allergy of any of the antibiotics used in the study, gastrointestinal malignancy, active upper gastrointestinal bleeding, pregnant and lactating women will be excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method